TactiFlex (ablative catheter for the treatment of arrhythmia)

2023: Catheter Announcement

On May 19, 2023, Abbott announced the release of the TactiFlex ablation catheter, the world's first product of this type with a unique flexible tip and contact pressure technology.

The novelty is intended for the treatment of arrhythmia. The catheter, in particular, can be used during surgical procedures aimed at eliminating atrial fibrillation (atrial fibrillation): this is a common heart rhythm disorder in which the upper chambers of the heart contract very quickly and non-rhythmically. Patients often feel dizziness and chest pain. In addition, atrial fibrillation can provoke a stroke. Ablation in this case is necessary to destroy small areas of heart tissue that cause atrial fibrillation.

TactiFlex (ablative catheter for the treatment of arrhythmia)

The TactiFlex catheter integrates with the Abbott EnSite X EP system, allowing surgeons to visualize the anatomy of the heart with high accuracy. As a result, the procedure time is reduced and safety is improved compared to previous generation ablative catheters. In general, the new radio frequency ablation system makes it possible to treat arrhythmia more effectively.

Unlike other catheters on the market, the TactiFlex product uses a laser-treated tip design that bends upon contact with the heart wall. This makes it possible to position the catheter more accurately, providing twice as much stability during operations on a beating heart.

Abbott notes that over 37 million people worldwide live with atrial fibrillation. The number is expected to more than double by 2050. About 5 million cases of this disease are diagnosed annually. Thus, the TactiFlex system is able to help a huge number of patients.^[1]

Notes